- Pfizer Inc. Technical Analysis [ http://www.StockCall.com/PFE011613.pdf ]
- Merck & Co. Inc. Technical Analysis [ http://www.StockCall.com/MRK011613.pdf ]
The vote on repealing and replacing Obamacare has been pulled from the House floor.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Merck KGaA shares tested one-year highs Friday after the Food & Drug Administration approved rare form of skin cancer treatment that could cost patients as much as $13,000 per month.